203
Views
6
CrossRef citations to date
0
Altmetric
Case Series

Ceftobiprole for Treatment of MRSA Blood Stream Infection: A Case Series

ORCID Icon, , , , , , ORCID Icon & show all
Pages 2667-2672 | Published online: 03 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Coleman Rotstein, Joseph P. Lynch$suffix/text()$suffix/text() & George G. Zhanel. (2023) Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) in Canada: treatment update and the role of new IV antimicrobials. Expert Review of Anti-infective Therapy 21:11, pages 1213-1225.
Read now

Articles from other publishers (5)

Gautam Kumar & Asha Kiran Tudu. (2023) Tackling multidrug-resistant Staphylococcus aureus by natural products and their analogues acting as NorA efflux pump inhibitors. Bioorganic & Medicinal Chemistry 80, pages 117187.
Crossref
John C. Lam & William Stokes. (2023) The Golden Grapes of Wrath – Staphylococcus aureus Bacteremia: A Clinical Review. The American Journal of Medicine 136:1, pages 19-26.
Crossref
George G. Zhanel, Justin Kosar, Melanie Baxter, Rita Dhami, Sergio Borgia, Neal Irfan, Kelly S. MacDonald, Gordon Dow, Philippe Lagacé-Wiens, Maxime Dube, Marco Bergevin, Carlo Tascini, Yoav Keynan, Andrew Walkty & James Karlowsky. (2021) Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry. Journal of Global Antimicrobial Resistance 24, pages 335-339.
Crossref
Tommaso Lupia, Carlo Pallotto, Silvia Corcione, Lucio Boglione & Francesco Giuseppe De Rosa. (2021) Ceftobiprole Perspective: Current and Potential Future Indications. Antibiotics 10:2, pages 170.
Crossref
. (2020) Daptomycin/vancomycin. Reactions Weekly 1819:1, pages 98-98.
Crossref